ҵ
ԱͣԱ
ѻƹ ȼ
(0 -40)ۣ
(41-90)ۣɽǢ̸
(91+ )ۣɳ
ƹԱ5
֤ʱ䣺
עţ ֤
˴ ֤
ҵͣ ֤
עʽ ֤
Ʒ86101
ι۴3724087
-
T31204Darapladib-impurityDarapladib impurity,Darapladibimpurity
Darapladib-impurity is the impurity of Darapladib. Darapladib inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2)
ţT31204 أй½
-
T67698WAY-300374WAY300374
WAY-300374 inhibits the p53-MDM2 protein-protein interaction.
ţT67698 أй½
-
T7848PT-2385Inhibitor,inhibit,Hypoxia-inducible factors,HIF/HIF Prolyl-Hydroxylase,HIF-PH,PT 2385,HIFs,PT
PT-2385 is a selective HIF-2 inhibitor (Kd<50 nM).
ţT7848 أй½
-
T15018CUDC-427
CUDC-427 is an orally bioactive and pan antagonist of inhibitor of apoptosis proteins(IAPs). CUDC-427 can be used in research on cancers.
ţT15018 أй½
-
TP1559LZiconotide Acetate (107452-89-1 free base)analgesic,non-opioid,Ziconotide Acetate (107452891 free
Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.
ţTP1559L أй½
-
T8439Clobenpropit dihydrobromideApoptosis,inhibit,Clobenpropit dihydrobromide,histamine H3R,antagonist,in
Clobenpropit dihydrobromide is a potent antagonist and inverse agonist of histamine H3R (histamine H3LR,pEC50 of 8.07)
ţT8439 أй½
-
T15641K777
K777 is a potent, orally active and irreversible inhibitor of cysteine protease. K777 is a potent CYP3A4 inhibitor (IC50= 60 nM). K777 is also a selective CCR4 antagonist featuring the potent chemotaxis inhibition. K777 irreversibly inhibits Cruzain, which is the major cysteine protease of Trypansoma cruzi, and cathepsins B and L. K777 targets cathepsin-mediated cell entry and wxibits a broad-spectrum antiviral activity. K777 inhibits EBOV and SARS-CoV pseudovirus entry with IC50 values of 0.87
ţT15641 أй½
-
T8331NUN82647NUN82647,Inhibitor,NUN 82647,inhibit,Apoptosis,QBS,NUN-82647
NUN82647 is an Inhibitor of cell cycle at G2 phase, and apoptosis inducer.
ţT8331 أй½
-
T9840AtaquimasAtaquimas
Ataquimast inhibits IL-5 secretion along with that of TNF-a, IL-4 and GM-CSF from human cells.
ţT9840 أй½
-
T27371FR-167356
FR-167356 is a specific inhibitor of a3 isoform vacuolar type H?-ATPase with IC50s of 170 nM, 370 nM and 220 nM for osteoclast plasma membranes, renal brush border membranes and macrophage microsomes. FR-167356 reduces bone metastasis of B16-F10 cells.
ţT27371 أй½
-
T6675Sodium Picosulfateinhibit,Inhibitor,Sodium Picosulfate
Sodium Picosulfate inhibits absorption of water and electrolytes, and increases their secretion.
ţT6675 أй½
-
T16940STAT5-IN-2STAT-5-IN-2,STAT5IN2,STAT5 IN 2
STAT5-IN-2 is an inhibitor of STAT5 with antileukemic effects (EC50s: 9 M and 5 M in K562 and KU812 cells, respectively).
ţT16940 أй½
-
TN2275Tinnevellin glucosideTinnevellin glucoside,inhibit,Inhibitor
Tinnevellin glucoside is a natural product from Cassia angustifolia.
ţTN2275 أй½
-
TN12955-O-Caffeoylshikimic acidinhibit,5 O Caffeoylshikimic acid,Inhibitor,5OCaffeoylshikimic acid
5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-B.
ţTN1295 أй½
-
TP1881L1Pep 2-8 ammonium salt(1541011-97-5 free base)Pep 2 8 ammonium salt(1541011 97 5 free base),Pep 28 am
Pep 2-8 ammonium salt is Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. Potent inhibitor of PCSK9 binding to LDL receptor (IC50 = 0.8 M). Restores LDL uptake in HepG2 cells treated with PCSK9.
ţTP1881L1 أй½
-
T22849ICI 199,441 hydrochlorideICI 199,441 hydrochloride
ICI 199,441 hydrochloride is a potent, selective agonist of -opioid receptor.
ţT22849 أй½
-
TQ0150LevcromakalimPotassium Channel,KcsA,Inhibitor,inhibit,BRL38227,BRL-38227,Levcromakalim
Levcromakalim is an activator of the ATP-sensitive K+ channel.
ţTQ0150 أй½
-
TN12373-O-Methylgallic acidAnthocyanin,3 O Methylgallic acid,inhibit,3OMethylgallic acid,metabolite,anti-c
3,4-Dihydroxy-5-methoxybenzoic acid reduces cell proliferation in Caco-2 cells(IC50 = 24.1 M) more effectively than anthocyanins and may offer protection against colon cancer after its formation in the gut. 3,4-Dihydroxy-5-methoxybenzoic acid inhibits transcription factors NF-B, AP-1, STAT-1, and OCT-1 which are known to be activated in colorectal cancer.
ţTN1237 أй½